Related Experiment Video

Updated: Sep 8, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Meningococcal vaccines

Delia Bethell1, Andrew J Pollard

  • 1Department of Paediatrics, University of Oxford, John Radcliffe Hospital, UK.

Expert Review of Vaccines
|August 12, 2003
PubMed

Insights

Meningococcal serogroup C conjugate vaccines have nearly eradicated childhood disease in the UK. Developing a serogroup B vaccine is the next challenge for eradicating invasive meningococcal disease.

Area of Science:

  • Vaccinology
  • Microbiology
  • Public Health

Background:

  • Invasive meningococcal disease (IMD) is a significant public health concern with high mortality.
  • Serogroup C meningococcal conjugate vaccines have been highly effective in reducing IMD in the UK.
  • Eradication of IMD is a feasible goal with further vaccine development.

Purpose of the Study:

  • To review the impact of meningococcal serogroup C conjugate vaccines.
  • To identify challenges and opportunities in eradicating invasive meningococcal disease.
  • To highlight the need for a serogroup B meningococcal vaccine.

Main Methods:

  • Review of existing literature and immunization program data.
  • Analysis of vaccine efficacy and impact on disease epidemiology.
  • Exploration of current and future vaccine development strategies.

Main Results:

  • Near-elimination of serogroup C meningococcal disease in UK children following vaccine introduction.
  • Demonstrated feasibility of eradicating IMD through vaccination.
  • Identification of serogroup B as the primary remaining obstacle to eradication.

Conclusions:

  • Protein-polysaccharide conjugate vaccines have revolutionized meningococcal disease prevention.
  • Development of a safe and immunogenic serogroup B vaccine is critical for IMD eradication.
  • Advances in genomics offer new avenues for identifying novel vaccine candidates.

More Related Videos

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

Related Concept Videos

Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...